HU9701658D0 - Method of preventing allograft rejection - Google Patents

Method of preventing allograft rejection

Info

Publication number
HU9701658D0
HU9701658D0 HU9701658A HUP9701658A HU9701658D0 HU 9701658 D0 HU9701658 D0 HU 9701658D0 HU 9701658 A HU9701658 A HU 9701658A HU P9701658 A HUP9701658 A HU P9701658A HU 9701658 D0 HU9701658 D0 HU 9701658D0
Authority
HU
Hungary
Prior art keywords
allograft rejection
preventing allograft
preventing
rejection
allograft
Prior art date
Application number
HU9701658A
Other languages
English (en)
Inventor
Henry James Showell
Elora Jeanne Weringer
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU9701658D0 publication Critical patent/HU9701658D0/hu
Publication of HUP9701658A2 publication Critical patent/HUP9701658A2/hu
Publication of HUP9701658A3 publication Critical patent/HUP9701658A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
HU9701658A 1996-10-17 1997-10-16 The use of benzopyran derivatives for production of pharmaceuticals for preventing allograft rejection HUP9701658A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2887896P 1996-10-17 1996-10-17

Publications (3)

Publication Number Publication Date
HU9701658D0 true HU9701658D0 (en) 1997-12-29
HUP9701658A2 HUP9701658A2 (hu) 1998-12-28
HUP9701658A3 HUP9701658A3 (en) 2000-12-28

Family

ID=21846021

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701658A HUP9701658A3 (en) 1996-10-17 1997-10-16 The use of benzopyran derivatives for production of pharmaceuticals for preventing allograft rejection

Country Status (10)

Country Link
US (1) US5948813A (hu)
EP (1) EP0836850A3 (hu)
JP (1) JPH10158164A (hu)
KR (1) KR19980032887A (hu)
AU (1) AU722215B2 (hu)
CA (1) CA2218306C (hu)
HU (1) HUP9701658A3 (hu)
IL (1) IL121931A (hu)
NZ (1) NZ328973A (hu)
ZA (1) ZA979262B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0963755A3 (en) * 1998-04-16 2001-03-14 Pfizer Products Inc. Use of benzopyranes for preventing allograft rejection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
WO1993015066A1 (en) * 1992-01-23 1993-08-05 Pfizer Inc. Benzopyran and related ltb4 antagonists
US5424320A (en) * 1993-06-23 1995-06-13 Merck Frosst Canada, Inc. Heteroaryl coumarins as inhibitors of leukotriene biosynthesis
CA2202056A1 (en) * 1994-10-13 1996-04-25 Mark A. Dombroski Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists
US5552437A (en) * 1994-10-27 1996-09-03 Merck Frosst Canada, Inc. Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
IL121931A (en) 2000-02-17
AU4185797A (en) 1998-04-23
EP0836850A2 (en) 1998-04-22
JPH10158164A (ja) 1998-06-16
KR19980032887A (ko) 1998-07-25
HUP9701658A3 (en) 2000-12-28
EP0836850A3 (en) 2000-11-29
CA2218306C (en) 2001-10-09
AU722215B2 (en) 2000-07-27
US5948813A (en) 1999-09-07
HUP9701658A2 (hu) 1998-12-28
NZ328973A (en) 2000-06-23
CA2218306A1 (en) 1998-04-17
IL121931A0 (en) 1998-03-10
ZA979262B (en) 1999-04-16

Similar Documents

Publication Publication Date Title
IL121186A0 (en) Stent fabrication method
EP0932415A4 (en) METHOD FOR PREVENTING A SOLID ORGANTRANSPLANTATION FOLLOWING ACUTE EXHAUST REACTION
PL333364A1 (en) Novel compounds and method of using them
PL332482A1 (en) Intermediate compounds for and method of obtaining olanzaoine
EP0847826A4 (en) METHOD OF DIFFUSION WELDING OF METAL MATERIALS
PL318452A1 (en) Method of obtaining peroxyperfluoropolyoxyalkylenes
PL330400A1 (en) Method of obtaining azacyclohexapeptides
PL331899A1 (en) Method of obtaining bis-indolyl malimides
IL124293A0 (en) Method and compositions for the reduction of xenotransplantation rejection
AU2323492A (en) Method for inhibiting allograft rejection
GB9713538D0 (en) Fabrication method of cmos device
PL332077A1 (en) Method of obtaining omepraole
PL313419A1 (en) Method of obtaining beta-naphtole
HU9901211D0 (en) Method of preventing allograft rejection
IL128731A0 (en) Method of preventing allograft rejection
PL333977A1 (en) Method of obtaining benzisothiazolyn-3-ones
AU2439297A (en) Method for detecting organ allograft rejection and uses thereof
ZA979262B (en) Method of preventing allograft rejection
EP0874707A4 (en) METHOD FOR MAKING A SLOTED COMPONENT
PL317788A1 (en) Method of obtaining 3-isocyanate-propylsilane
PL332075A1 (en) Method of obtaining nizathidine
GB9621751D0 (en) Method of separation
AU1752999A (en) Method for preventing transplant rejection
AU4371296A (en) Compositions and methods for preventing and treating allograft rejection
PL332208A1 (en) Method of obtaining benzzothiophenes